Generated by AI
Alpha Teknova, Inc. is a life sciences reagents company that develops and manufactures products used in research, bioprocessing, and molecular diagnostics. Its offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements, and molecular biology reagents for sample manipulation, resuspension, and purification. The company serves a broad customer base across the biotechnology, pharmaceutical, diagnostics, academic, and government research markets, supporting workflows tied to drug development, vaccine development, and advanced therapies. Alpha Teknova also provides custom and catalog solutions designed for laboratory and manufacturing applications, with products used in cell and gene therapy, synthetic biology, and other life science workflows. Headquartered in Hollister, California, Alpha Teknova plays a specialized role in the supply chain that enables scientific research and the production of biopharmaceutical products.
Website2451 Bert Dr.
Hollister, CA, 95023
United States
The latest articles about TKNO.
Alpha Teknova Inc (TKNO) posted record Q3 2026 revenue of $12.2 million, up 22% year-over-year, as Clinical Solutions jumped 86% and gross margin expanded to 38.0%.
Summary of Mar 10's posts. Generated by AI.
No summary yet.
Summary of Jul 17's posts. Generated by AI.
No summary yet.
Summary of Mar 10's posts. Generated by AI.
Investors talking about TKNO also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.